Flow cytometry revealed that PRMT5 knockdown increased the percentage of DLBCL cells in the G0/G1 phase and decreased the percentage of DLBCL cells in the S phase (Fig. 7F and Fig. S13). Here, PRMT5 is linked to diffuse large B-cell lymphoma.